Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Paragraph: Bryant’s action came despite a federal judge’s ruling last year that struck down a less-restrictive law limiting abortions in the state. The New York-based Center for Reproductive Rights called the new measure “cruel and clearly unconstitutional” and said it would sue Mississippi to try to block the law from taking effect on July 1. After a bill signing ceremony at the state Capitol, Bryant told reporters that he’s not worried about lawsuits. “They don’t have to sue us. It’s up to them,” Bryant said. “If they do not believe in the sanctity of life, these that are in organizations like Planned Parenthood, we will have to fight that fight. But it is worth it.” Mississippi is one of several states that have considered bills this year to ban abortions once a fetal heartbeat is found. Abortion opponents are emboldened by new conservatives on the Supreme Court and are seeking cases to challenge Roe v. Wade, the court’s 1973 ruling that legalized abortion nationwide. A federal judge in 2018 struck down a Mississippi law that would ban most abortions after 15 weeks of pregnancy, saying it is unconstitutional. The ruling came in a lawsuit filed by the only remaining abortion clinic in Mississippi. “Lawmakers didn’t get the message,” Hillary Schneller, staff attorney for the Center for Reproductive Rights, said in a statement Thursday. “They are determined to rob Mississippians of the right to abortion, and they are doing it at the expense of women’s health and taxpayer money. This ban — just like the 15-week ban the governor signed a year ago — is cruel and clearly unconstitutional.”  The law that Bryant signed Thursday says a physician who performs an abortion after a fetal heartbeat is detected could face revocation of his or her Mississippi medical license. It also says abortions could be allowed after a fetal heartbeat is found if a pregnancy endangers a woman’s life or one of her major bodily functions. The House and Senate both rejected efforts to allow exceptions for pregnancies caused by rape or incest. Georgia and Tennessee are among the states considering similar bills. Kentucky’s law banning abortion after the detection of a heartbeat was immediately challenged by the American Civil Liberties Union when Republican Gov. Matt Bevin signed it on March 14, and a federal judge temporarily blocked it. A federal judge on Wednesday also blocked another Kentucky law that would ban abortion for women seeking to end their pregnancies because of the gender, race or disability of the fetus. Dr. Leana Wen, a physician who is president of Planned Parenthood Federation of America, said in a statement Thursday that the new Mississippi law “is a dangerous policy that criminalizes a safe, standard medical procedure and will endanger women’s lives.” “Patients must be empowered to make their own health care decisions, in consultation with their doctor and their family, and doctors must be able to provide health care to our patients without the threat of prison time,” Wen said. “We cannot accept a world where the right to abortion care depends on where you live or how much money you make.” Jameson Taylor, vice president for policy at the conservative Mississippi Center for Public Policy, praised Bryant for signing the bill. “The heartbeat bill is popular because everyone knows a heartbeat is a sign of life,” Taylor said in a statement. “Intellectual and scientific honesty demands a reconsideration of Roe, a 50-year-old decision based on old science. 3-D and 4-D ultrasounds are showing women that their unborn child is alive.” ____ Follow Emily Wagster Pettus on Twitter at http://twitter.com/EWagsterPettus . Claim: Mississippi governor signs ‘heartbeat’ abortion law.
Mississippi Gov. Phil Bryant on Thursday signed one of the strictest abortion laws in the nation — a measure that bans most abortions once a fetal heartbeat can be detected, about six weeks into pregnancy.

Paragraph: A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008. REUTERS/Toby Melville The GlaxoSmithKline Plc vaccine Rotarix fights infection with the rotavirus, which causes about 55,000 hospitalizations in U.S. children each year and kills more than 600,000 children worldwide, mostly in developing countries. Rotarix already is approved in more than 100 other countries throughout the world. The vaccine competes with Merck & Co Inc’s rotavirus vaccine called RotaTeq. Without vaccination, nearly every child in the United States likely would be infected at least once with rotavirus by age five, the Food and Drug Administration said. In studies of more than 24,000 infants, Rotarix prevented severe and mild cases of rotavirus-caused diarrhea and vomiting during the first two years of life. “This vaccine provides another option to combat and reduce a potentially severe illness that affects so many children,” Dr. Jesse Goodman, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement announcing the Rotarix approval. The most common reactions reported during clinical trials were fussiness, irritability, cough, runny nose, fever, loss of appetite and vomiting, the FDA said. An earlier oral rotavirus vaccine sold by Wyeth was pulled from the market in 1999 after it was linked to a rare, life-threatening type of bowel obstruction known as intussusception. In a Glaxo study of more than 63,000 infants, there was no increase in the problem compared with a placebo. Higher rates of convulsion and pneumonia-related deaths were seen in Rotarix patients in that study but not in other Glaxo trials. “Although the FDA has concluded that the available data do not establish that these events are related to the vaccine, the agency has requested the manufacturer to conduct post-marketing safety studies involving more than 40,000 infants to provide additional safety information,” the FDA said. Glaxo said Rotarix “will offer protection against the most commonly circulating rotavirus types in the U.S. and allow infants to complete the vaccination series by four months of age.”   Rotarix, which is a liquid, is given in two doses to infants from six to 24 weeks of age, the FDA said. Merck’s RotaTeq vaccine is administered in three doses from ages six weeks to 32 weeks. Sales of Rotarix were $182 million in 2007 and are expected to rise with approval in the large U.S. market. The vaccine will be commercially available in the United States in the second half of the year, Glaxo said. Also on Thursday, researchers reported that Rotarix provided protection for up to two years in a study of infants from 10 Latin American countries. The Glaxo-funded trial of more than 15,000 infants found severe diarrhea from rotavirus in 0.4 percent of children given the vaccine, compared with 2.3 percent in the placebo group. Results were published in the Lancet medical journal. The arrival of a new generation of oral vaccines against the disease has been welcomed by health-care workers, but some experts caution against assuming the vaccines will work equally well in all countries. In a commentary in the Lancet, Australian pediatric experts Keith Grimwood and Carl Kirkwood noted Rotarix was more effective in European trials than in middle-income Latin American countries. The World Health Organization “is awaiting efficacy data from low-income countries of Africa and Asia, where much greater strain diversity exists and where 413,000 deaths occur every year compared with 15,000 in Latin America and 200 in Europe,” Grimwood and Kirkwood wrote. Claim: Glaxo wins FDA clearance for rotavirus vaccine.
A second oral vaccine to prevent a leading cause of severe diarrhea in infants won approval from U.S. health officials on Thursday.

Paragraph: Maple Leaf Foods President and CEO Michael McCain addresses shareholders at the company's annual general meeting in Toronto April 26, 2006. Canadian health officials said on Monday 12 people have died out of 26 confirmed cases of listeriosis, a food poisoning that genetic tests linked to prepared meats from a Toronto plant owned by Maple Leaf Foods Inc <MFI.TO>. REUTERS/J.P. Moczulski There are another 29 suspected cases of listeriosis, officials told reporters, and Agriculture Minister Gerry Ritz said the government expected more cases in coming days. Maple Leaf Foods, one of Canada’s biggest meat processors, had said it hoped to reopen the Toronto plant associated with the outbreak on Tuesday, but health officials said they will test and hold all meat produced there until they are satisfied it is not contaminated. “The timeframe really isn’t theirs. It belongs more to the (Canadian Food Inspection Agency),” Ritz said. Maple Leaf has voluntarily pulled about 220 products made at the plant in one of the biggest food recalls ever in Canada, with direct costs to the company of about C$20 million ($19 million). Listeria bacteria with the same genetic fingerprint as that found in the ill people was found in two beef products made at the plant. Those products and about 20 others made on the same lines were recalled last week. Listeriosis, an illness that is particularly dangerous for pregnant women, the elderly, infants and people with weak immune systems, was a contributing factor in seven of the deaths, the Public Health Agency of Canada said. Five others had the bacteria in their system, but the causes of their deaths are still under investigation, said the agency’s Mark Raizenne. Previously, four deaths had been attributed to the outbreak. Maple Leaf has said it’s unlikely it will be able to determine how its meat was contaminated, explaining that the listeria bacterium is common and pervasive. “It’s very, very, very difficult, if not impossible, to pinpoint a cause,” Chief Financial Officer Michael Vels told analysts on Monday before the latest health announcement. “I don’t know how important that is to consumers. I think our perspective is what’s more important is we let them know what’s going on and we take swift and conservative action to safeguard their health,” Vels said. Maple Leaf is double-checking procedures at all of its 23 plants but has no reason to believe any other products are at risk of contamination, he said. Reimbursing customers for returned products, cleaning the plant and other direct expenses will cost the company C$20 million before taxes, Vels said. On top of the company’s initial cost estimate, it may face reduced sales and increased advertising costs, he said. Maple Leaf shares closed 10 percent lower at C$8.80 ahead of the announcement of the latest deaths. Vels declined to speculate on whether Maple Leaf would have any financial liability from lawsuits, but said the company has product liability insurance. “No definitive link has been made between the listeria causing the illness and deaths, and Maple Leaf products,” Vels told analysts. But a lawyer known for aggressively pursuing class action lawsuits, including against tainted pet food maker Menu Foods Income Fund, said his firm will take action against Maple Leaf. “It’s apparent, immediately, that the company has been downplaying the significance of what’s going on,” Tony Merchant said in an interview with CTV News. ($1=$1.05 Canadian) Claim: Canada says 12 dead in food poisoning outbreak.

Twelve people have now died out of 26 confirmed cases of food poisoning linked to deli meats produced at a plant owned by Maple Leaf Foods Inc, Canadian health officials said Monday.